180 Life Sciences Corp. Warrant ATNFW

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.00 (+6.25%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of 180 Life Sciences Corp. Warrant (ATNFW)
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.008699

  • Price-Earnings Ratio

    0.00

  • Total Outstanding Shares

    1.03 Million Shares

  • Total Employees

    4

  • Dividend

    No dividend

  • IPO Date

    June 27, 2017

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Warrant

  • Headquarters

    3000 el camino real, Palo alto, CA, 94306

  • Homepage

    https://www.180lifesciences.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities$462,994
Net Cash Flow From Financing Activities, Continuing$462,994
Net Cash Flow From Operating Activities, Continuing$-2.69 Million
Exchange Gains/Losses$-240,674
Net Cash Flow From Operating Activities$-2.69 Million
Net Cash Flow$240,674

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Income/Loss Attributable To Parent$-3.12 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Revenues$0
Net Income/Loss Available To Common Stockholders, Basic$-3.12 Million
Diluted Earnings Per Share$7.98
Net Income/Loss$-3.12 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-3.26 Million
Comprehensive Income/Loss$-3.26 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$-3.26 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Noncurrent Liabilities$352,252
Equity Attributable To Parent$3.73 Million
Current Assets$1.23 Million
Intangible Assets$9.24 Million
Assets$10.47 Million
Noncurrent Assets$9.24 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ATNFW from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.